MedPath

NYU LANGONE HEALTH

NYU LANGONE HEALTH logo
๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
Private
Established
1841-01-01
Employees
10K
Market Cap
-
Website
http://www.nyulangone.org

Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy

Phase 2
Completed
Conditions
Pain
Postoperative Depression
Interventions
Other: Placebo Comparator
Drug: Ketamine
First Posted Date
2015-05-22
Last Posted Date
2020-03-16
Lead Sponsor
NYU Langone Health
Target Recruit Count
90
Registration Number
NCT02452060
Locations
๐Ÿ‡บ๐Ÿ‡ธ

NYU Langone Medical Center, New York, New York, United States

Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users

Phase 4
Completed
Conditions
Alcohol Dependence
Alcohol Use Disorder
Interventions
Drug: XR-NTX+CM (Extended-Release Naltrexone plus Care Management)
First Posted Date
2015-05-15
Last Posted Date
2022-05-11
Lead Sponsor
NYU Langone Health
Target Recruit Count
50
Registration Number
NCT02445339
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Bellevue Hospital Center, New York, New York, United States

Effectiveness of Astym Treatment For de Quervain's Tenosynovitis

Not Applicable
Completed
Conditions
de Quervain's Disease
Interventions
Device: Occupational therapy with ASTYM
Other: Occupational therapy
First Posted Date
2015-05-13
Last Posted Date
2020-10-09
Lead Sponsor
NYU Langone Health
Target Recruit Count
32
Registration Number
NCT02442622
Locations
๐Ÿ‡บ๐Ÿ‡ธ

NYU Langone Medical Center, Center for Musculoskeletal Care, New York, New York, United States

Pierre Robin Sequence Outcome Assessment Multi Institutional Study

Withdrawn
Conditions
Pierre Robin Sequence
First Posted Date
2015-05-04
Last Posted Date
2017-11-22
Lead Sponsor
NYU Langone Health
Registration Number
NCT02432638
Locations
๐Ÿ‡บ๐Ÿ‡ธ

NYU School of Medicine, New York, New York, United States

A Comparison of Intra-op Ketamine vs Placebo in Patients Having Spinal Fusion

Phase 4
Completed
Conditions
Postoperative Pain
Interventions
Other: Placebo
Drug: Ketamine
First Posted Date
2015-04-23
Last Posted Date
2017-06-14
Lead Sponsor
NYU Langone Health
Target Recruit Count
46
Registration Number
NCT02424591
Locations
๐Ÿ‡บ๐Ÿ‡ธ

NYU School of Medicine, New York, New York, United States

The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals

Phase 1
Completed
Conditions
Religious or Spiritual Problem
Interventions
First Posted Date
2015-04-20
Last Posted Date
2022-02-14
Lead Sponsor
NYU Langone Health
Target Recruit Count
12
Registration Number
NCT02421263
Locations
๐Ÿ‡บ๐Ÿ‡ธ

NYU Langone Medical Center/Tisch Hospital, New York, New York, United States

Efficacy of Vitamin D Therapy on Glucose Homeostasis in Obese Adolescents

Not Applicable
Completed
Conditions
Vitamin D Deficiency
Interventions
Drug: Placebo
Drug: Vitamin D2
First Posted Date
2015-04-10
Last Posted Date
2017-03-17
Lead Sponsor
NYU Langone Health
Target Recruit Count
20
Registration Number
NCT02414529
Locations
๐Ÿ‡บ๐Ÿ‡ธ

bellevue hospital CTSI, New York, New York, United States

An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery

Phase 4
Withdrawn
Conditions
Uterine Atony
Postpartum Hemorrhage
Interventions
First Posted Date
2015-04-07
Last Posted Date
2017-07-31
Lead Sponsor
NYU Langone Health
Registration Number
NCT02410655

Potential Restoration of the Infant Microbiome

Not Applicable
Withdrawn
Conditions
Human Microbiome
Interventions
Other: Newborn exposure to mother vaginal microbiota
First Posted Date
2015-04-02
Last Posted Date
2018-01-12
Lead Sponsor
NYU Langone Health
Registration Number
NCT02407184

Feasibility of Telephone Follow-up Visits in Primary Care

Phase 4
Completed
Conditions
No Specific Condition
Interventions
Other: Telephone Visit
First Posted Date
2015-03-19
Last Posted Date
2016-04-06
Lead Sponsor
NYU Langone Health
Target Recruit Count
11
Registration Number
NCT02393534
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Gouverneur TDC, New York, New York, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath